Molecular Imaging of Breast Cancer With Breast PET/CT
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Phase 1
Contacts and Locations
Study Locations
-
-
California
-
Sacramento, California, United States, 95817
- UC David Medical Center
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Normal Adult Volunteers
- Female, at least 18 years of age
- Ability to lie motionless for up to 20 minutes
Patient Volunteers
- Female, at least 18 years of age
- Diagnostic findings from prior mammography highly suggestive of invasive breast carcinoma (BI-RADS category 5)
- Not pregnant or breast-feeding
- Ability to lie motionless for up to 20 minutes
Exclusion Criteria:
Normal Adult Volunteers
- Inability to understand the risks and benefits of the study
Patient Volunteers
- Recent breast biopsy
- Diagnostic findings from prior mammography highly suggestive of noninvasive ductal or lobular carcinoma
- Uncontrolled diabetes
- Diabetic and blood sugar level > 200 mg/dL
- Positive urine pregnancy test or currently breast-feeding
- Inability to understand the risks and benefits of the study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Other: 1
Normal volunteers
|
Positron emission tomography and computed tomography
Other Names:
|
|
Active Comparator: 2
Breast PET/CT scan
|
Positron emission tomography and computed tomography
Other Names:
|
|
Active Comparator: 3
Whole body and breast PET/CT
|
Positron emission tomography and computed tomography
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
End-points of this study are whether women will accept the imaging position and timing, and whether functional properties of breast cancer can be imaged with this device.
Time Frame: 5 years
|
5 years
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Ramsey Badawi, PhD, University of California, Davis
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 200715040
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.